A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Antibodies (immunoglobulins) are Y-shaped proteins with variable domains (Fv) recognizing antigen and constant domains mediating effector functions. The Fab region binds antigen with high specificity; the Fc region engages Fc receptors on immune cells and activates complement. Antibodies neutralize pathogens, opsonize for phagocytosis, activate complement, and mediate antibody-dependent cellular cytotoxicity (ADCC).
Draw antibody structure with heavy and light chains, disulfide bonds, CDRs, and hinge region. Relate each structural domain to specific functions (e.g., CDRs to binding, Fc to effector functions).
Not all Fc-binding functions are equally important for all isotypes. Variable domains recognize antigen, but constant domains drive distinct effector functions in different tissues.
Antibodies are the secreted effector molecules of activated B cells, and their Y-shaped structure is one of biology's most elegant examples of modular design. The shape is not incidental — it encodes a strict division of labor between antigen recognition and immune effector recruitment, allowing a single molecule to both find its target with exquisite specificity and then trigger a pre-built destruction program.
Each antibody consists of two identical heavy chains and two identical light chains held together by disulfide bonds at the hinge region. The molecule can be cleaved into functional fragments: the two Fab (Fragment antigen-binding) arms and the single Fc (Fragment crystallizable) stem. The Fab arms carry the variable (V) domains, whose tips form the antigen-binding sites. Within the variable domains, three hypervariable loops called complementarity-determining regions (CDRs) make direct contact with antigen. CDR sequences vary enormously between different B cell clones — this variation is the molecular basis of antibody diversity and specificity. The Fc region, by contrast, is largely constant within an immunoglobulin class and does not contact antigen; it is the business end for effector recruitment.
Antibodies eliminate pathogens through several distinct effector mechanisms, each mediated by the Fc region. Neutralization — blocking viral entry or toxin binding — is the only mechanism mediated directly by antigen binding in the Fab arms, requiring no Fc engagement. For all other mechanisms, Fc is essential. Opsonization occurs when the Fc region of antigen-bound antibodies is recognized by Fc receptors (FcγRs) on macrophages and neutrophils, triggering phagocytosis of the tagged target. Complement activation begins when C1q in the complement cascade binds arrays of Fc regions on an antibody-coated surface, initiating a proteolytic cascade that ends in target lysis. Antibody-dependent cellular cytotoxicity (ADCC) is triggered when NK cells bind Fc-tagged target cells through their own Fc receptors (FcγRIII / CD16) and deliver a lethal hit.
A common misconception is that Fc is a passive structural handle. In reality, Fc structure determines isotype-specific behavior: IgA is secreted across mucosal surfaces because its Fc engages the polymeric immunoglobulin receptor on epithelial cells; IgG crosses the placenta through neonatal Fc receptor (FcRn)-mediated transcytosis, conferring passive immunity on the fetus; IgE binds high-affinity FcεRI receptors on mast cells to trigger allergic responses. Therapeutic monoclonal antibodies are now routinely engineered at the Fc region — sometimes with mutations to enhance ADCC for cancer immunotherapy, sometimes to silence effector function entirely for applications where cytokine release would be harmful. Understanding that variable domains set specificity and constant domains set activity class is the conceptual key to the entire field of antibody biology.